Marksans Pharma has acquired a 100% stake in Dubai-based Access Healthcare for AED 13 million in a cash deal. The deal was approved by the Board of Directors of Marksans Pharma on April 23 and is expected to be completed by June 30. At the closing of this transaction, shareholders of Access Healthcare will receive AED 13 million.

Access Healthcare for Medical Products or Access Healthcare is a pharma company that offers marketing and sales solution throughout the Middle East and the North African region. Access Healthcare registered revenue of AED 12 million (roughly Rs 25 crore) at the end of December 2021. The company’s profit after tax deduction was AED 4.5 million or INR 94 million.

Marksans Pharma on the other hand supplies products through the Dubai Health Authority or DHA. With this deal, Marksans will use Access Healthcare to market products manufactured in the Indian, American and British regions. Marksans plans to strengthen its position in the North African and Middle East region by using Access Healthcare’s network of partners and distributors. 

Marksans Pharma was founded in 1992 and was funded by 2 investors - SpringHill Management and UTI Ventures. They have raised Rs 218 million in a post-IPO Equity round.